339 related articles for article (PubMed ID: 23467704)
1. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
[TBL] [Abstract][Full Text] [Related]
2. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
[TBL] [Abstract][Full Text] [Related]
3. Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas.
Tanaka J; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Uchida K; Kojima T; Takei Y
Int J Oncol; 2010 Oct; 37(4):805-14. PubMed ID: 20811701
[TBL] [Abstract][Full Text] [Related]
4. TLR3 dsRNA agonist inhibits growth and invasion of HepG2.2.15 HCC cells.
Chen L; Xu YY; Zhou JM; Wu YY; E Q; Zhu YY
Oncol Rep; 2012 Jul; 28(1):200-6. PubMed ID: 22552584
[TBL] [Abstract][Full Text] [Related]
5. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the efficacy of talazoparib and the functional toll-like receptors 3 and 9 in triple negative breast cancer.
Guney Eskiler G; Deveci Özkan A
Mol Immunol; 2022 Jan; 141():280-286. PubMed ID: 34906906
[TBL] [Abstract][Full Text] [Related]
7. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
8. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells.
Holm CK; Petersen CC; Hvid M; Petersen L; Paludan SR; Deleuran B; Hokland M
J Immunol; 2009 Oct; 183(7):4422-31. PubMed ID: 19748983
[TBL] [Abstract][Full Text] [Related]
9. Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells.
Guo Z; Chen L; Zhu Y; Zhang Y; He S; Qin J; Tang X; Zhou J; Wei Y
Oncol Rep; 2012 Feb; 27(2):396-402. PubMed ID: 22075935
[TBL] [Abstract][Full Text] [Related]
10. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
[TBL] [Abstract][Full Text] [Related]
11. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
[TBL] [Abstract][Full Text] [Related]
12. Expression and role of Toll-like receptors on human umbilical cord mesenchymal stromal cells.
Chen D; Ma F; Xu S; Yang S; Chen F; Rong L; Chi Y; Zhao Q; Lu S; Han Z; Pang A; Han Z
Cytotherapy; 2013 Apr; 15(4):423-33. PubMed ID: 23352460
[TBL] [Abstract][Full Text] [Related]
13. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells.
Harashima N; Inao T; Imamura R; Okano S; Suda T; Harada M
Cancer Immunol Immunother; 2012 May; 61(5):667-76. PubMed ID: 22038398
[TBL] [Abstract][Full Text] [Related]
14. Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
Chiron D; Pellat-Deceunynck C; Maillasson M; Bataille R; Jego G
J Immunol; 2009 Oct; 183(7):4371-7. PubMed ID: 19734228
[TBL] [Abstract][Full Text] [Related]
15. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9.
Lebre MC; van der Aar AM; van Baarsen L; van Capel TM; Schuitemaker JH; Kapsenberg ML; de Jong EC
J Invest Dermatol; 2007 Feb; 127(2):331-41. PubMed ID: 17068485
[TBL] [Abstract][Full Text] [Related]
16. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
Jiang Q; Wei H; Tian Z
BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
[TBL] [Abstract][Full Text] [Related]
17. Synergy of CpG oligodeoxynucleotide and double-stranded RNA (poly I:C) on nitric oxide induction in chicken peripheral blood monocytes.
He H; Genovese KJ; Nisbet DJ; Kogut MH
Mol Immunol; 2007 May; 44(12):3234-42. PubMed ID: 17339052
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
[TBL] [Abstract][Full Text] [Related]
19. Phosphorothioate modification of the TLR9 ligand CpG ODN inhibits poly(I:C)-induced apoptosis of hepatocellular carcinoma by entry blockade.
Zhang Y; Lin A; Sui Q; Zhang C; Tian Z; Zhang J
Cancer Lett; 2014 Dec; 355(1):76-84. PubMed ID: 25224571
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.
Matsumoto M; Kikkawa S; Kohase M; Miyake K; Seya T
Biochem Biophys Res Commun; 2002 May; 293(5):1364-9. PubMed ID: 12054664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
